Open Government Canada
Notice of clarification to drug manufacturers and sponsors: Canadian-specific considerations in risk management plans
Published by Health Canada | Santé Canada
About this dataset
We are issuing this notice to help drug manufacturers and sponsors when preparing the Canadian-specific considerations and elements in the risk management plans (RMPs) for certain drug products. This notice describes what is required for certain drug products.